Stay updated on Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page's revision metadata was updated, adding new last update dates (2026-08-31, 2027-06-30, 2028-05-31) and a new revision identifier (v3.6.6). The older revision marker (v3.6.5) appears to have been superseded.
    Difference
    0.2%
    Check dated 2026-09-02T19:19:01.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Additional funding information was added to the study record, listing a 2017 U.S. NIH grant/contract. This update clarifies the NIH support behind the trial and its funding source.
    Difference
    0.0%
    Check dated 2026-08-26T21:42:03.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.5, replacing the previous v3.6.4, indicating a version update of the study details page.
    Difference
    0.0%
    Check dated 2026-08-12T20:53:57.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.3 to v3.6.4, indicating a new release version without altering the displayed study details.
    Difference
    0.0%
    Check dated 2026-07-22T15:57:19.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added a new PubMed publication entry for Shitara et al. on first-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma. The citation shows Nat Med 2026 Jun;32(6):2182-2190 with an Epub date of 2026 Mar 16, replacing the earlier Online ahead of print note.
    Difference
    0.0%
    Check dated 2026-07-15T13:23:06.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision tag updated to v3.6.3, replacing the previous v3.6.0 on the page. This indicates a new site revision without altering study details.
    Difference
    0.0%
    Check dated 2026-07-01T10:17:53.000Z thumbnail image

Stay in the know with updates to Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.